🌱 KidneyEnergy.com

← brief for 2026-08-12 · Slowing decline

Comparative effectiveness of finerenone versus steroidal mineralocorticoid receptor antagonists on sepsis-induced cardiomyopathy in patients with diabetic kidney disease: a real-world cohort study.

Article C Peer reviewed Observational

Key takeaways

This study compared finerenone, a kidney and heart drug, with older water-pill-type drugs in people who have diabetic kidney disease. It looked at heart muscle trouble caused by severe infection (sepsis). Because it watched real-world records, it can show a link, not prove the drug caused the difference.

Who did this work

Wu JY · Lee KW · Huang SC · Chang HY · Lin YM

Source

Article · PubMed, the drug frontier · 2026 Jul 28
https://pubmed.ncbi.nlm.nih.gov/42582336/